Changes in Operation Profits in Korea's E-cigarette Market

Apr.12.2023
Changes in Operation Profits in Korea's E-cigarette Market
South Korean e-cigarette market sees changes in profits for major participants, with PMI rebounding and KT&G leading with 84% share.

On April 11th, according to a report by South Korean media outlet Bizwatch, there have been some new developments in the profit margins of major players in the country's electronic cigarette market. PhiMo International Korea saw a 163% increase in operating profit in 2022, while BAT Korea's operating profit decreased by 12%. KT&G has a profit margin of 30% and holds a market share of 84%, making it the top player in the South Korean market.


PMI's operating profit rebounds against market trends.


In 2022, there will be changes in the revenue of KT&G, PMI Korea, and BAT Korea.


KT&G and PMI Korea are the top two players in the South Korean electronic cigarette market, while BAT Korea is facing a growth standstill.


Analysts of the South Korean tobacco industry believe that the future profit lies in the electronic cigarette market as the tobacco industry shifts from traditional cigarettes to electronic ones.


According to industry insiders, in 2022, PMI's South Korean company's sales reached KRW 686.8 billion, representing a 21.5% increase compared to 2021. Operating profit increased by 162.5%, reaching KRW 80.6 billion. The operating profit margin increased from 5.4% in 2021 to 11.7% in 2022.


In 2022, KT&G's revenue was 36.94 trillion Korean won, representing a 5.8% increase from 2021. During this period, operating profit grew by 3.4% to reach 11.23 trillion Korean won, resulting in an operating profit margin of 30.3%.


KT&G's overseas tobacco exports and e-cigarette sales drove the growth, as demand for the domestic tobacco market decreased by 1% in 2022. KT&G's overseas cigarette sales in 2022 amounted to KRW 1.98 trillion, a 47.2% increase from 2021. Additionally, the sales of the company's next-generation product (NGP), with 2022 sales totaling KRW 87.63 billion, grew by 73.9%.


BAT Korea reported a 14.3% increase in revenue for 2022, reaching KRW 539.8 billion. However, the company's operating profit decreased by 12% to KRW 44.6 billion, resulting in a decline in operating profit margin from 10.7% in 2021 to 8.3% in 2022. Additionally, the net profit for 2022 decreased by 33.6%, reaching KRW 28.5 billion.


The market share of electronic cigarettes continues to grow.


Although cigarettes still dominate the South Korean tobacco market with a market share of approximately 85%, electronic cigarettes are rapidly replacing traditional cigarettes and are becoming the driving force behind the future profits of tobacco companies.


According to the "2022 Tobacco Market Trends" report released by the South Korean Ministry of Strategy and Finance, the market share of electronic cigarettes in the domestic tobacco market has been steadily increasing since 2017, rising from 2.2% to 9.6% in 2018, 10.5% in 2019, 10.6% in 2020, 12.4% in 2021, and 14.8% in 2022. After a period of stagnation in 2019 and 2020, the market share has been on the rise since 2021.


Changes in Market Share of E-cigarettes | Image Source: 2FIRSTS


In 2022, KT&G held a market share of 47.5% in convenience stores. Additionally, KT&G's electronic cigarette equipment made up 84% of the market share in the same year.


PMI's South Korean company has been actively targeting the electronic cigarette market, launching a new lineup called "IQOS Illuma One" in February 2023 after introducing iCos Illuma in October 2022.


Although KT&G and PMI compete in the domestic market, they have formed an alliance overseas. In January 2023, KT&G signed a 15-year agreement to provide PMI with smoke-free products in the international market (excluding South Korea). In exchange for marketing, distribution, and sales rights of KT&G e-cigarettes overseas, PMI guarantees a minimum distribution of cigarette units to ensure KT&G's profitability.


On the other hand, as reported, BAT has a market share of approximately 10% in the South Korean e-cigarette market. The company recently launched 'Glo HyperX2' in Korea with the goal of rebounding, but there hasn't been a significant shift in market share yet.


According to a Korean industry insider, "After a period of stagnation, the domestic e-cigarette market has slowly grown since 2022, and the challenge is how to further develop the market.


Related reading:


PMI's South Korean outsourcing factory has invested KRW 300 billion for the production of HNB devices.


Demand for heated tobacco in South Korea is expected to surge by 21% in 2022, while cigarette demand is set to decline by 1.8%.


References:


Last year's cigarette sales report shows that BAT Korea failed to meet its targets.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company has begun selling four flavored Vuse Pro pods — Peach, Berry, Watermelon and Fresh Mint — in Ohio and selected other U.S. markets. According to the Vuse U.S. FAQ, Vuse Pro contains approximately 5.0% nicotine by weight, and Vuse Pro pre-filled pods are intended for use with Vuse Alto devices. Reynolds told 2Firsts that product labeling lists an e-liquid capacity of 2.0 mL per pod. The Vuse Alto Power Unit received FDA marketing authorization in 2024, while the new Vuse Pro pods themselves have not received marketing granted orders. The rollout follows the FDA’s May 2026 revision of enforcement priorities for certain unauthorized vaping products with qualifying pending applications.
BAT
Sep.10
JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show
JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show
At the 2026 NACS Show in Las Vegas, JTI Liggett highlighted its value-priced cigarette portfolio, including LD and Montego, following JT Group's acquisition of Vector Group. The company's U.S. business reported market share gains, with LD sales volume rising 32.6% in the first half of 2026. Meanwhile, Ploom was displayed separately at Altria's booth under an existing partnership. JTI Liggett booth staff told 2Firsts that the company had not yet launched nicotine pouch products in the United States.
EXPO
Oct.09
U.S. Expands Illicit Vape Enforcement as ATF Brings PACT Act Powers Into Trade Fraud Task Force
U.S. Expands Illicit Vape Enforcement as ATF Brings PACT Act Powers Into Trade Fraud Task Force
The U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives said on September 23 that it has joined the interagency Trade Fraud Task Force to strengthen enforcement against illegal, misdeclared and smuggled vape and tobacco products. ATF will bring its authority under the Prevent All Cigarette Trafficking Act into the task force, including registration, reporting, shipping and record-inspection requirements covering interstate sales of electronic nicotine delivery systems. ATF said the move will strengthen its ability to trace illicit products from U.S. points of entry through domestic trafficking and distribution networks.
News
Sep.28 by 2Firsts Perspectives
Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings
Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings
During its coverage of Altria's booth at NACS Show 2026, 2Firsts documented product displays that prompted questions about U.S. tobacco advertising warning requirements. Following public comments from a former FDA official, 2Firsts sought responses from Altria and independently consulted U.S. regulatory lawyer Azim Chowdhury. Altria maintained that its B2B communications complied with applicable laws, while Chowdhury explained that federal warning rules provide no general trade-show exemption for e-cigarettes and nicotine pouches. The special report examines the broader regulatory implications.
Nov.04
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
FDA CTP Director Bret Koplow used his FDLI keynote in Washington to outline how the agency is rethinking the PMTA framework. He discussed category-specific review, nicotine pouch and sPMTA pilots, AI-assisted review, a 70% reduction in pending applications, and a major staffing constraint: CTP currently has only nine scientific review teams. He also reaffirmed tobacco harm reduction while stressing youth protection, flavored products, risk communication, and the challenge of unauthorized e-cigarettes.
Regulations
Oct.06
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Philip Morris International (PMI) has launched ZYN Melts in the UK, introducing a fully dissolvable oral nicotine tablet format alongside the brand's existing nicotine pouches. The range includes Cool Mint and Peppermint, each offered at 1mg and 2mg of nicotine per tablet, creating four SKUs. Each can contains 20 tablets and is priced at £6.50 in the UK. Unlike ZYN nicotine pouches, Melts are placed between the upper lip and gum and dissolve completely during use.
News
Sep.29 by 2Firsts Perspectives